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To test the “tinnitus gap-filling” hypothesis in an animal psychoacoustic paradigm, rats
were tested using a go/no-go operant gap detection task in which silent intervals of vari-
ous durations were embedded within a continuous noise. Gap detection thresholds were
measured before and after treatment with a dose of sodium salicylate (200 mg/kg) that
reliably induces tinnitus in rats. Noise-burst detection thresholds were also measured to
document the amount of hearing loss and aid in interpreting the gap detection results.
As in the previous human psychophysical experiments, salicylate had little or no effect on
gap thresholds measured in broadband noise presented at high-stimulus levels (30–60 dB
SPL); gap detection thresholds were always 10 ms or less. Salicylate also did not affect
gap thresholds presented in narrowband noise at 60 dB SPL. Therefore, rats treated with
a dose of salicylate that reliably induces tinnitus have no difficulty detecting silent gaps as
long as the noise in which they are embedded is clearly audible.
Keywords: gap detection, operant conditioning, threshold, tinnitus, prepulse inhibition, rat model, sodium
salicylate, sensorineural hearing loss
INTRODUCTION
The ototoxic effects of high doses of salicylate, the active ingre-
dient in aspirin, are well-established (1–4). A recent review by
Sheppard et al. (5) details the peripheral and central effects of sal-
icylate along with the known perceptual deficits seen in humans
following large doses of aspirin (5). Peripherally, acute doses of
salicylate affect outer hair cell (OHC) and auditory nerve func-
tion, causing a reduction in distortion product otoacoustic emis-
sions (DPOAE) and cochlear compound action potentials (CAP),
respectively (6, 7). Centrally, systemic administration of salicy-
late amplifies sound-evoked activity in the auditory cortex (AC)
to high-intensity sounds despite reduced neural output from the
cochlea (8, 9). Also, salicylate alters spontaneous firing rates (10)
and tonotopic organization in the AC (7).
In addition to electrophysiological studies, some of the per-
ceptual effects of salicylate have been cataloged. Depending upon
the dose, humans and rats typically develop hearing loss, with
temporary threshold shifts of ~5–20 dB SPL, following salicylate
administration (1, 2, 11, 12). In addition to hearing loss, salicylate
also disrupts auditory temporal processing for normal-hearing
human listeners. With moderate doses of aspirin, McFadden et al.
(13) found increased gap detection thresholds (impaired temporal
resolution) at low sound-pressure levels and flatter than normal
temporal integration functions (impaired temporal integration).
These aspirin-induced changes in temporal resolution and tempo-
ral integration are similar to the temporal processing deficits seen
in listeners with sensorineural hearing loss (14, 15). Thus, aspirin-
induced hearing loss has been proposed as a model of temporary
sensorineural hearing loss in humans (13).
In addition to inducing temporary hearing loss and temporal
processing deficits, salicylate also reliably induces tinnitus, i.e., a
phantom auditory perception, in humans (2). Given its tinnitus-
inducing properties, salicylate was used to test the first animal
model of tinnitus (16), and most of the current animal behav-
ioral models of tinnitus have been assessed using salicylate [see
Ref. (17, 18) for recent reviews of animal models of tinnitus].
Regarding behavioral models of tinnitus, one of the most widely
used animal behavioral paradigm for tinnitus uses a modified
gap detection paradigm. Based on the hypothesis that tinnitus
fills in the silent gap, the gap prepulse inhibition of the acoustic
startle reflex (Gap-PPI) paradigm has been used to assess both
salicylate- and noise-induced tinnitus in a number of species
(19–25).
In a typical Gap-PPI paradigm, a 50 ms silent interval embed-
ded in 60 dB SPL continuous noise is presented ~100 ms before a
high-intensity noise burst used to evoke the startle reflex motor
response (26, 27). Normal subjects hear the silent gap, which func-
tions as a warning signal (cue) that the startle stimulus is about
to occur, and reduces the amplitude of the startle reflex. However,
the “tinnitus gap-filling” hypothesis postulates that if a subject has
tinnitus, the phantom sound “fills in silence” and interferes with
processing of the silent gap, thereby preventing the silent interval
from inhibiting the startle reflex. The greatest deficit in Gap-PPI
presumably occurs when the spectral properties of the background
noise match the tinnitus pitch (28–30). Consequently, narrowband
noise (NBN) Gap-PPI has been used to estimate the tinnitus pitch
(19, 29, 31).
Gap-PPI has been widely used by many researchers, includ-
ing our group, to identify animals that presumably have noise- or
drug-induced tinnitus (19–21, 23). Gap-PPI paradigms attempt
to avoid the problem of drug- or noise-induced impairments
in temporal resolution by employing 50 ms gaps presented in
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at least 60 dB SPL background noise, durations and intensities
that are typically well above threshold. Therefore, researchers have
assumed that impaired Gap-PPI is not due to impaired tempo-
ral resolution per se, but rather to tinnitus interfering with the
processing of the silent gap (24).
However, since the effect of salicylate on auditory temporal res-
olution has not been directly investigated in rats, it is not clear
whether temporal processing deficits, hearing loss, tinnitus, or
some other perceptual deficit can explain changes in Gap-PPI
performance following salicylate administration (1, 32). There-
fore, the goal of the current study is to determine the effects of
salicylate on conscious gap detection performance in rats.
To evaluate basic temporal resolution in rats, we treated rats
with a dose of salicylate (200 mg/kg IP) known to induce tin-
nitus (4) and obtained gap detection thresholds for broadband
and NBNs. If the 50 ms gaps in 60 dB background noise cannot
be detected after salicylate treatment, then this would support
the hypothesis that tinnitus fills in silent intervals in their con-
scious perceptions. However, if gap detection thresholds remain
largely unchanged following salicylate administration, then it is
unlikely that tinnitus is filling in the silent interval and prevent-
ing the 50 ms gap from being consciously perceived. Although
the conscious perception of silent gaps in psychoacoustic tasks
is likely different than the mechanisms involved in the sub-
cortical Gap-PPI paradigm, this study will provide important
information for evaluating what is modeled in animal mod-
els of tinnitus, i.e., hearing loss, temporal processing deficits, or
hyperacusis (32).
MATERIALS AND METHODS
SUBJECTS
Six female Sprague-Dawley rats were used in the gap detection
experiments, and three of these six rats were used to obtain noise
thresholds (Note: two rats developed tumors and had to be sac-
rificed before their gap detection thresholds in NBN could be
obtained, and one rat had a broken tooth preventing her from
being used during the NBN detection experiment). The rats began
training at ~4 months of age and they were tested until they were
~14–15 months of age. The rats were obtained from Charles River
Laboratories and all procedures were approved by the University
at Buffalo, SUNY’s Institutional Animal Care and Use Committee.
All rats were housed separately and were kept on a 12 h day/night
cycle (lights on at 6 a.m.; lights off at 6 p.m.). Rats were food
restricted and kept at ~85% of their free-feeding weight during
the course of the experiment. Test sessions lasted ~1 h, and the
rats were run once per day, 6–7 days/week.
GAP DETECTION PROCEDURES
Apparatus
Rats were tested in an acoustically transparent acrylic cage
(28 cm× 30 cm× 38 cm) located inside a sound attenuating
chamber (76 cm× 71 cm× 71 cm) lined with 5 cm thick sound
attenuating foam (Illbruck, Inc., Minneapolis, MN, USA). The
behavior of the animals during test sessions was monitored by a
digital camera (Fire-i Digital Camera, Unibrain, San Ramon, CA,
USA). The test cage was equipped with a speaker (FT28D Dome
Tweeter, Fostex, Tokyo, Japan), feeder (Med Associates Model
ENV-203M, St. Albans, VT, USA), and nose-poke hole equipped
with infrared sensors (Vulintus, Dallas, TX, USA).
The experiment was run using custom behavioral software run-
ning on a personal computer (Microsoft Windows XP) similar
to that described previously (4). The custom software controlled
Tucker-Davis Technologies (TDT, Gainesville, FL, USA) system-3
equipment and operant hardware. Sound stimuli were generated
with TDT hardware and software (TDT RX6 processor, D/A con-
verter, ~100 kHz sampling rate); digital inputs to and outputs
from the testing cages were controlled by the TDT RX6 proces-
sor interfaced to a pellet feeder (Med Associates Model SG-501, St.
Albans,VT,USA) and infrared sensors (Vulintus,Dallas,TX,USA).
TDT RPvds software and custom MATLAB software (MathWorks,
Nattick, MA, USA) were used to control all aspects of the exper-
iment. Sound-pressure levels were calibrated using a sound level
meter (Larson-Davis System 824) equipped with a microphone
(1/4′′ free field microphone, model 2520, Larson-Davis, Depew,
NY, USA) placed at the position where the animal’s head would be
when it poked its nose into the nose-poke hole.
Procedure
The stimuli used in the gap detection experiments were a continu-
ous broadband noise (BBN) containing frequencies up to 42 kHz,
and 3 continuous NBNs: 10–20 kHz (1 octave bandwidth, centered
at 14.14 kHz), 16–20 kHz (4 kHz bandwidth), and 15.3–16.7 kHz
(1/8th octave bandwidth centered at 16 kHz). The BBN was pre-
sented at 20, 30, 40, and 60 dB SPL, and the NBNs were presented
at 60 dB SPL. The rats were trained using a go/no-go operant con-
ditioning procedure to detect a silent gap embedded within the
continuous noise.
The rat began a trial by nose poking through the nose-poke
hole, which initiated a variable waiting interval ranging from 1 to
4 s. During this time, the rat had to maintain its position in the
nose-poke hole; failure to do so resulted in an aborted trial. After
the waiting interval, a single silent gap was presented in the noise.
In the go condition, the target stimulus was the silent gap. In this
trial type, a hit was recorded if the rat correctly responded to the
gap within 2 s by removing its nose from the nose-poke hole and
receiving a food pellet (45 mg dustless rodent grain pellets, Bio-
Serv, Frenchtown, NJ, USA). A miss was recorded if the rat failed
to remove its nose from the nose-poke.
Approximately 30% of all trials were catch trials. These consti-
tuted the no-go part of the procedure and the silent gap was absent
during these trials. False alarm (FA) rates and response biases were
calculated from these catch trials. If the rat removed its nose dur-
ing a catch trial, a false alarm was recorded and the rat received a 4 s
timeout, during which the house light was turned off and the rat
could not initiate another trial. However, if the subject continued
to nose-poke, a correct rejection was recorded. No reinforcement
was given for a correct rejection, but the next trial began immedi-
ately. Chance performance was represented by the animal’s false
alarm rate. Sessions were excluded from analysis if the percentage
of FAs was >20%. Less than 1% of all sessions were excluded for
this reason.
The target stimuli were presented according to the psychophys-
ical method of constant stimuli (MOCS). Within each 10-trial
block, 7 predetermined targets were presented randomly along
Frontiers in Neurology | Neuro-otology February 2015 | Volume 6 | Article 31 | 2
Radziwon et al. Salicylate-induced gap detection deficits
with 3 catch trials. During testing, the target gaps were chosen
so that the smallest one or two gaps were rarely detected by the
rats, whereas the largest gaps were well above threshold and nearly
always detected. The gap durations used for testing were adjusted
depending on each rat’s performance.
Sodium salicylate administration
After baseline gap detection thresholds were collected, the rats were
tested once per week with either a single injection of sodium salicy-
late (200 mg/kg IP) dissolved in saline (50 mg/ml), or an equivalent
volume of saline (control). The injections were administered 2 h
before testing. The 200 mg/kg dose of sodium salicylate has pre-
viously been shown to reliably induce tinnitus-like behavior in
rats (4, 33).
Data analysis
Signal detection analysis was employed to factor out the animals’
motivational biases (34). Mean hit and false alarm rates were used
to calculate all gap thresholds using signal detection theory and a
threshold criterion of d ′= 1.5. This d ′ value is comparable to that
used by others (35–37) and ensures that the animal is responding
primarily to the target stimuli and not randomly (38).
NOISE DETECTION PROCEDURES
Apparatus
The apparatus for this part of the study was the same as that used
in the gap detection experiment.
Procedure
The spectra of the noise-burst stimuli used in the noise detection
experiments were the same as in the gap detection study, namely,
BBN and the three NBNs (10–20, 16–20, and 15.3–16.7 kHz).
Each noise stimulus was 300 ms in duration with cosine rise/fall
times of 5 ms. Rats were trained using a go/no-go operant con-
ditioning procedure to detect a noise burst in an otherwise quiet
chamber.
The procedure for obtaining the noise-burst thresholds was
nearly identical to the procedures used in the gap detection exper-
iment, but the target stimuli in the go condition for this experiment
were noise bursts embedded in a quiet background. Approximately
30% of all trials were catch trials, and no stimulus was presented
on no-go trials. Noise-burst threshold testing began when the ani-
mals finished the gap detection experiment. As in the gap detection
experiment, noise bursts were presented using the MOCS. The
target intensities were chosen so that only the lowest one or two
intensities were not detected whereas the highest sound levels were
well above threshold.
Sodium salicylate administration
After baseline noise-burst thresholds were collected, the rats were
tested once per week with either a single injection of sodium salicy-
late (200 mg/kg IP) dissolved in saline (50 mg/ml) or an equivalent
volume of saline (control). As in the gap detection experiments,
the injections were administered 2 h before testing.
Data analysis
The data analysis for this study was the same as that used in the
gap detection experiment.
RESULTS
GAP DETECTION
Gap detection in broadband noise
Table 1 shows the individual and mean gap detection thresholds
in BBN at 30, 40, and 60 dB SPL for baseline, saline, and salicylate
conditions along with gap detection thresholds for 20 dB SPL for
baseline and saline conditions. Data could not be collected for the
20 dB SPL-salicylate condition because the rats were unable to per-
form the task. This was most likely due to the salicylate-induced
hearing loss that resulted in the 20 dB BBN being below or near the
threshold of audibility as determined in the subsequent threshold
detection experiment (Table 1).
Effect of intensity on BBN gap thresholds
Figure 1A shows the mean BBN gap thresholds at 30, 40, and 60 dB
SPL for all six rats for baseline, saline, and salicylate conditions.
In addition, the gap thresholds for baseline and saline are shown
for 20 dB SPL; however, we were unable to collect reliable data for
salicylate at 20 dB SPL. For baseline and saline conditions, mean
BBN gap detection thresholds increased slightly from ~2 to 3 ms
as the sound level decreased from 60 to 30 dB SPL, but at 20 dB
SPL, gap thresholds increased to 4–6 ms. A two-way repeated mea-
sures analysis of variance (ANOVA) of the baseline and saline gap
threshold obtained at 20–60 dB SPL showed a significant effect of
intensity (F = 15.77, 3 df; p< 0.001) and a significant interaction
between intensity and baseline and saline conditions (F = 11.79,
Table 1 | Individual and mean broadband noise gap thresholds (ms)
vs. intensity (dB SPL) for baseline, saline, and salicylate conditions.
Subject Condition BBN
(60dB SPL)
BBN
(40dB SPL)
BBN
(30dB SPL)
BBN
(20dB SPL)
Green 1 Baseline 2.1 ms 2.1 ms 2.7 ms 3.7 ms
Saline 1.8 ms 2.3 ms 2.2 ms 3.8 ms
Salicylate 2.0 ms 2.9 ms 11.3 ms NC
Green 2 Baseline 1.3 ms 1.6 ms 2.4 ms 2.9 ms
Saline 1.7 ms 1.8 ms 2.7 ms 5.7 ms
Salicylate 1.5 ms 2.6 ms 3.9 ms NC
Green 3 Baseline 1.8 ms 1.7 ms 2.7 ms 3.9 ms
Saline 1.9 ms 2.0 ms 1.7 ms 6.9 ms
Salicylate NA 3.8 ms NA NC
Purple 1 Baseline 1.9 ms 2.1 ms 2.7 ms 3.3 ms
Saline 2.3 ms 2.0 ms 2.4 ms 3.7 ms
Salicylate 2.2 ms 2.5 ms 5.2 ms NC
Purple 2 Baseline 1.5 ms 2.4 ms 3.0 ms 7.9 ms
Saline 1.7 ms 2.6 ms 2.8 ms 9.7 ms
Salicylate 1.6 ms 4.5 ms 17.7 ms NC
Purple 3 Baseline 1.8 ms 1.8 ms 2.9 ms 4.4 ms
Saline 2.2 ms 1.5 ms 2.5 ms 6.5 ms
Salicylate 1.4 ms 3.0 ms 12.0 ms NC
Mean Baseline 1.72 ms 1.94 ms 2.71 ms 4.32 ms
Saline 1.93 ms 2.03 ms 2.38 ms 6.05 ms
Salicylate 1.74 ms 3.22 ms 10.02 ms NC
NA, data not available; NC, data not collected.
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3 df, p< 0.001). A Holm–Sidak multiple comparison of the base-
line condition revealed a significant difference in gap thresholds
between 20 and 60 dB and 20 and 40 dB (p< 0.01); a similar analy-
sis of the saline condition revealed a significant difference between
20 and 30 dB, 20 and 40 dB, and 20 and 60 dB (p< 0.05).
Mean gap thresholds during salicylate treatment were similar
to baseline and saline at 60 dB SPL (Figure 1A; Table 1). At 40 dB
SPL, mean gap thresholds increased from 2 ms pre-treatment to
about 3 ms during salicylate; however, at 30 dB SPL, gap detec-
tion thresholds increased from ~3 ms pre-treatment to roughly
10 ms during salicylate, but did not exceed 18 ms in any of the
salicylate-treated rats (Table 1; range: 3.9–17.7 ms).
A two-way repeated measures ANOVA with three sound levels
(30, 40, and 60 dB SPL) and three conditions (baseline, saline,
and salicylate) as factors revealed a significant effect of con-
dition (F = 14.77, 2 df, p< 0.001), intensity (F = 16.50, 2 df,
p< 0.001), and a significant interaction between condition and
sound level (F = 9.53, 4 df, p< 0.001). A Holm–Sidak post hoc
analysis revealed significant differences between the salicylate and
saline conditions (p< 0.05) at 30 dB SPL and between salicylate
and baseline conditions (p< 0.05) at 30 dB SPL, but not at 40
and 60 dB SPL (p> 0.05). Within the saline treatment group,
the Holm–Sidak post hoc analysis revealed a significant differ-
ence between 30 and 60 dB SPL (p< 0.05) and 30 and 40 dB
SPL (p< 0.05). No significant differences were found between
the baseline and saline conditions for any of the sound levels
(p> 0.05).
Mean BBN gap detection thresholds for the saline and salicy-
late conditions were subsequently re-plotted by sensation level (dB
SL) in Figure 1B to more clearly illustrate the effects of salicylate-
induced hearing loss on gap detection performance. The mean SLs
were calculated by subtracting the mean thresholds from the noise-
burst detection experiment (dB SPL) from the sound presentation
level of the stimulus. In addition, gap detection thresholds were
also plotted for normal-hearing Mongolian gerbils across five
sensation levels (35). The reason for including the gerbil data
was to demonstrate that gap detection deficits are apparent with
decreasing sound level in normal-hearing animals with similar
hearing sensitivity and temporal processing abilities as rats. There-
fore, when corrected for hearing loss and re-plotted by sensation
level, the gap detection deficits seen following an injection of sal-
icylate appear to be the result of hearing loss alone without the
additional explanation of tinnitus “filling in” the silent gap.
Gap detection in narrowband noise
Gap detection thresholds were also obtained at 60 dB SPL for
three NBNs (10–20, 16–20, and 15–17 kHz) located near the most
sensitive region of the rat’s audiogram and in the vicinity of the
presumed tinnitus pitch (7, 19, 39). The purpose of this experi-
ment was to determine if salicylate-induced tinnitus could “fill-in”
the silent gap in NBN. Table 2 shows the gap detection thresh-
olds in BBN and the three NBNs at 60 dB SPL for each rat across
the baseline, saline, and salicylate conditions. Mean thresholds for
the four rats are plotted in Figure 2 (two of the six rats previ-
ously tested in the BBN condition died before their gap detection
thresholds in NBN could be obtained), and mean psychometric
functions are plotted in Figure 3. Generally, gap detection thresh-
olds increased as the bandwidth of the noise became narrower;
however, gap detection thresholds for each NBN did not change
significantly after the rats were injected with salicylate.
In a two-way repeated measures ANOVA with three condi-
tions (baseline, saline, and salicylate) and four noise bandwidths
(BBN, 10–20, 16–20, and 15–17 kHz) as factors, the gap thresh-
old differences among the three conditions were not great enough
to exclude the possibility that the differences were due to chance
[F(2,45)= 0.42, p> 0.05], and there was no significant interaction
between condition and bandwidth [F(6,45)= 2.16, p> 0.05].
NOISE THRESHOLDS
Table 3 shows broadband and NBN thresholds in quiet for each of
the three rats that were tested in the baseline, saline, and salicylate
conditions (Note: two of the original six rats died before noise
FIGURE 1 | (A) Mean (SEM) gap thresholds for BBN presented at
intensities from 20 to 60 dB SPL for baseline, saline, and salicylate (SS,
200 mg/kg) conditions. Gap thresholds could not be measured at 20 dB
SPL during salicylate treatment. (B) Mean (SEM) gap detection
thresholds for the current saline and salicylate (SS, 200 mg/kg) data
re-plotted in dB SL (sensation level). Mean (SEM) gap detection
thresholds for white noise are also plotted for the Mongolian gerbil
across five sensation levels (35).
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Table 2 | Individual and mean gap detection thresholds (ms) for
broadband noise (BBN) and narrowband noise (NBN) at 60dB SPL.
Subject Condition BBN
(60dB
SPL)
10–20 kHz
NBN
(60dB SPL)
16–20 kHz
NBN
(60dB SPL)
15–17 kHz
NBN
(60dB SPL)
Green 1 Baseline 2.1 ms 2.05 ms 4.4 ms 3.4 ms
Saline 1.8 ms 2.5 ms 4.3 ms NA
Salicylate 2.0 ms 2.9 ms 3.7 ms 3.4 ms
Green 3 Baseline 1.8 ms 2.5 ms 3.95 ms 3.5 ms
Saline 1.9 ms 2.7 ms 4.5 ms 3.9 ms
Salicylate NA 2.6 ms 3.7 ms 3.9 ms
Purple 2 Baseline 1.5 ms 3.05 ms 3.5 ms 3.55 ms
Saline 1.7 ms 2.1 ms 4.6 ms 3.8 ms
Salicylate 1.6 ms 5.9 ms 6.5 ms 7.0 ms
Purple 3 Baseline 1.75 ms 4.1 ms 4.6 ms 4.8 ms
Saline 1.93 ms 3.3 ms 4.7 ms 5.1 ms
Salicylate 1.74 ms 3.5 ms 4.2 ms 5.1 ms
Mean Baseline 1.72 ms 2.93 ms 4.11 ms 3.81 ms
Saline 1.93 ms 2.65 ms 4.53 ms 4.27 ms
Salicylate 1.74 ms 3.73 ms 4.53 ms 4.85 ms
NA, data not available.
FIGURE 2 | Mean (SEM) gap thresholds for BBN and three NBNs
obtained for baseline, saline, and salicylate (SS, 200mg/kg) conditions.
thresholds could be obtained and one rat had a broken tooth dur-
ing threshold testing so complete thresholds are shown for three
rats). Since one rat, Purple 2, could not perform in the NBN thresh-
old conditions due to a tooth problem, mean performance for the
other three rats is plotted in Figure 4 and statistics were only
carried out using the three rats that could complete all thresh-
old conditions. However, BBN thresholds for rat Purple 2 were
included in Table 3 for comparison.
Mean thresholds were the lowest for BBN and the 10–20 kHz
NBN and 7–9 dB higher for the 10–20 and 15–17 kHz NBN. Noise
thresholds for BBN, 10–20 kHz NBN, 16–20 kHz NBN, and 15–17
NBN during the salicylate condition increased ~18, 19, 16, and
20 dB, respectively, compared to the saline control condition. A
two-way repeated measures ANOVA with three conditions (base-
line, saline, and salicylate) and four noise bandwidths (BBN,
10–20, 16–20, and 15–17 kHz) as factors revealed significant main
effects of condition [F(2,35)= 322.8, p< 0.001] and noise band-
width [F(3,35)= 26.2, p< 0.001], but there was no significant
interaction between condition and bandwidth [F(6,35)= 0.80,
p> 0.05]. Holm–Sidak post hoc tests found significant differences
between the salicylate and saline conditions (p< 0.05), and the
salicylate and baseline conditions (p< 0.05) for all four noises,
with the salicylate condition having significantly higher thresholds
than the baseline and saline conditions. No significant differences
were found between the baseline and saline conditions for any
of the noises (p> 0.05). The post hoc analyses also revealed sig-
nificant differences between BBN and the 16–20 and 15–17 kHz
NBNs (p< 0.05), but not the 10–20 kHz NBN (p> 0.05). Over-
all, the 16–20 and 15–17 kHz NBNs consistently produced higher
thresholds than the BBN and 10–20 kHz NBN.
DISCUSSION
NORMAL GAP DETECTION THRESHOLDS IN RATS
Most gap detection studies employ BBN stimuli to minimize prob-
lems associated with spectral splatter and off-frequency listening
(40, 41). Our baseline BBN gap detection thresholds in Sprague-
Dawley rats were in the 2–3 ms range from 30 to 60 dB SPL
(~28–58 dB SL). However, at 20 dB SPL (~18 dB SL) mean gap
thresholds increased to 4.3 ms. Our BBN gap thresholds are in
good agreement to those previously reported in rats (42, 43), mice
(37, 44), chinchillas (45), gerbils (35), and humans (13, 40, 46),
and show a clear increase as intensity falls below 30 dB SPL.
Our NBN gap thresholds measured at 60 dB SPL were larger
than those obtained in BBN (Figure 2; Table 2). The gap thresh-
olds for the two narrowest NBNs (16–20 and 15–17 kHz) were
~1 ms longer than the 10–20 kHz NBN gap threshold, which in
turn was roughly 1 ms longer than the BBN. These results indi-
cate that gap thresholds improve (decrease) as stimulus bandwidth
increases. Few animal studies have examined the role of stimulus
bandwidth on gap detection performance (37, 47) and, to date,
no studies have examined the role of frequency and bandwidth
on gap detection in rats. However, our results are consistent with
human studies that show an improvement in gap thresholds with
increasing stimulus bandwidth (48–53).
EFFECTS OF SALICYLATE ON GAP DETECTION THRESHOLDS
The main goal of the current project was to determine if a dose
of salicylate sufficient to induce hearing loss and tinnitus would
significantly impair gap detection performance in rats. However,
since previous research in normal-hearing humans (40) and ani-
mals (35, 37, 45) has found that gap detection thresholds increase
significantly with decreasing stimulus intensity, hearing loss is
a primary confounding variable when assessing gap detection
thresholds in hearing-impaired listeners. In other words, for all
species tested, gap detection thresholds increase with decreasing
sound level, regardless of tinnitus or any other temporal processing
deficit (35, 40). As a result, the hearing loss induced by salicylate
needs to be considered when evaluating our gap detection results.
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FIGURE 3 | Mean (SEM) psychometric functions in the BBN (60dB SPL) and NBN (60dB SPL) gap detection experiments for saline and salicylate (SS,
200mg/kg) conditions. False alarm (FA) rates are also plotted.
Because the 200 mg/kg dose of salicylate increased the BBN
threshold from 2 to 19 dB SPL (Table 3), it was not technically
feasible to measure gap thresholds with the 20 dB SPL BBN due to
the fact that the signal was essentially undetectable at this inten-
sity. However, gap thresholds increased to 10 ms at 30 dB SPL
(Figure 1); though this increase is most likely due to the fact that
the BBN was now only 10 dB above threshold versus ~28 dB above
threshold before salicylate treatment (Table 3). These results are in
line with previous research in animals (35, 37, 45) and humans (13,
40) showing increased gap detection thresholds with decreasing
stimulus intensity (Figure 1B).
Gap detection thresholds at 40 and 60 dB SPL were largely
unaffected by salicylate treatment. Likewise, NBN gap detection
thresholds measured at 60 dB SPL were largely unaffected by sal-
icylate treatment; mean gap thresholds increased by <1.08 ms
post-salicylate when compared to saline values (Figure 2), and
salicylate thresholds only appeared to increase in one rat, Purple
2 (Table 2). However, since NBN threshold measurements could
not be taken from this rat due to illness, it is possible that this rat
had more hearing loss as a result of salicylate treatment than the
other rats. This rat’s (Purple 2) BBN threshold following salicylate
administration was the highest of all four rats tested and was at
least 3.6 dB SPL higher than the next highest threshold (Table 3).
Taken together, our results mirror gap detection data in humans
indicating that salicylate had little or no effect on the detection
of silent gaps embedded in BBN or NBN as long as the signals
remained audible and well above threshold (13).
Even under the most difficult listening conditions post-
salicylate (30 dB SPL BBN), gap thresholds never exceeded 18 ms
in any of the animals tested (Table 1). The changes in gap detection
we observed in rats treated with 200 mg/kg salicylate are similar to
those observed in humans treated with a high doses of aspirin,
whose active ingredient is salicylate (13). The dose of aspirin
employed in the McFadden et al. (13) study-induced hearing losses
ranging from 4 to 18 dB in humans. Gap detection thresholds,
assessed with low- and high-frequency octave-band noise, were
unaffected by the aspirin-induced hearing loss at moderate and
high intensities, but increased by ~15 ms at low intensities. There-
fore, as in the McFadden et al. (13) study, the increase in gap
thresholds at low SPLs in our experiment is most likely the result
Frontiers in Neurology | Neuro-otology February 2015 | Volume 6 | Article 31 | 6
Radziwon et al. Salicylate-induced gap detection deficits
Table 3 | Individual broadband noise (BBN) and narrowband noise (NBN) thresholds.
Subject Condition BBN 10–20 kHz NBN 16–20 kHz NBN 15–17 kHz NBN
Green 1 Baseline 2.6 dB SPL 1.6 dB SPL 6.8 dB SPL 11.3 dB SPL
Saline 1.2 dB SPL 2.7 dB SPL 6.7 dB SPL 7.7 dB SPL
Salicylate 17.7 dB SPL 16.1 dB SPL 26.3 dB SPL 30.5 dB SPL
Green 3 Baseline 2.0 dB SPL −0.5 dB SPL 12.0 dB SPL 8.1 dB SPL
Saline 1.5 dB SPL −0.7 dB SPL 8.1 dB SPL 6.5 dB SPL
Salicylate 21.1 dB SPL 22.6 dB SPL 24.5 dB SPL 26.8 dB SPL
Purple 2 Baseline 4.8 dB SPL NA NA NA
Saline 7.1 dB SPL NA NA NA
Salicylate 24.7 dB SPL NA NA NA
Purple 3 Baseline 1.8 dB SPL 1.0 dB SPL 9.2 dB SPL 7.7 dB SPL
Saline −0.1 dB SPL −1.2 dB SPL 8.6 dB SPL 4.0 dB SPL
Salicylate 18.3 dB SPL 19.2 dB SPL 19.8 dB SPL 21.7 dB SPL
Mean Baseline 2.80 dB SPL 0.67 dB SPL 9.28 dB SPL 9.00 dB SPL
Saline 2.43 dB SPL 0.27 dB SPL 7.80 dB SPL 6.07 dB SPL
Salicylate 20.45 dB SPL 19.30 dB SPL 23.53 dB SPL 26.33 dB SPL
According to this table, a 20 dB SPL BBN following an injection of salicylate would only be 2.3 and 1.7 dB above threshold for green 1 and purple 3, respectively; the
BBN would be below threshold for Purple 2 and Green 3.
NA, data not available.
FIGURE 4 | Mean (SEM) thresholds for BBN and three NBN
bandwidths (see legend) during baseline, saline and salicylate (SS,
200mg/kg) conditions for three rats. BBN data from one rat, Purple 2,
were not shown in this graph because her thresholds could not be
collected for the NBN conditions.
of the salicylate-induced hearing loss rather than an impairment
in temporal resolution caused by tinnitus “filling in” the conscious
perception of the silent gap.
TINNITUS GAP-FILLING HYPOTHESIS
In addition to providing important animal psychoacoustic data,
our results also have implications for tinnitus research. One of the
most widely used animal behavioral models of tinnitus, Gap-PPI,
operates on the hypothesis that tinnitus interferes with processing
silent gaps in noise (19, 21–23, 29, 31). Most Gap-PPI paradigms
employ a 50 ms silent gap embedded in an ongoing 60 dB SPL
background noise to suppress the acoustic startle reflex response.
Gap stimuli embedded in BBN or NBN strongly inhibit the startle
response; but, if an animal is exposed to intense noise or given
a high dose of salicylate, the silent gap no longer suppresses the
startle response. This lack of prepulse inhibition has been hypoth-
esized to occur because the phantom sound of tinnitus “fills in”
the 50 ms silent intervals in the noise thereby preventing the
silent gap from suppressing the subsequent acoustic startle reflex
(19–21, 24, 25, 31).
However, this “tinnitus gap-filling” hypothesis has been eval-
uated in only three human studies to date. Two of these human
studies used psychoacoustic procedures to determine whether tin-
nitus interferes with the conscious perception of silent gaps in
noise. Campolo et al. (30) found that when tinnitus patients with
pre-existing hearing loss were asked if they could detect 50 ms
silent gaps embedded in 15 dB SL NBN that was centered above,
below, or at their tinnitus frequency, tinnitus patients had no dif-
ficulty detecting the 50 ms gaps and performed as well as normal-
hearing subjects (30). More recently, Boyen et al. (54) found that
human tinnitus patients had similar gap detection thresholds com-
pared to a matched non-tinnitus control group even when the test
frequency matched the patient’s tinnitus frequency (54).
The third recent human study used an eye-blink Gap-PPI par-
adigm to test gap detection in tinnitus patients (55). Fournier
and Hébert (55) found that patients with high-frequency hear-
ing loss and high-pitched tinnitus had less Gap-PPI than normal
controls at high frequencies, but they also had less Gap-PPI at
low frequencies where there was no tinnitus. If the high-pitched
tinnitus was filling in the silent gap, the authors reasoned that
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the tinnitus patients should have impaired Gap-PPI only at the
high frequencies and not the low frequencies (55). Furthermore,
since the tinnitus group in the Fournier and Hébert (55) study
had a high-frequency hearing loss while the control group did
not, it is not surprising that their tinnitus subjects would show
greater gap detection deficits than the control subjects given that
previous research has shown that high-frequency information is
important for sensitive gap detection performance. When high fre-
quencies are unavailable to a subject, either through a hearing loss
or through filtering of the test stimuli, gap detection thresholds
increase (15, 37, 40, 42, 48).
Our current psychophysical results provide the first test of the
“tinnitus gap-filling” hypothesis in an animal. The results of our
gap detection experiment mirror the results found in the human
psychophysical gap detection tests (13,30, 54), and suggest that tin-
nitus does not “fill-in” the silent gap in tasks requiring conscious
perception.
THE CONFOUNDING EFFECTS OF SALICYLATE AND NOISE EXPOSURE
One of the difficulties in developing an animal behavioral model
of tinnitus is controlling for the confounding effects of the tinnitus
inducer, i.e., salicylate or noise exposure (18, 56). In addition to
tinnitus, salicylate is also known to induce hearing loss in humans
and animals (1, 13), temporal resolution and integration deficits in
humans (13), and hyperacusis in animals (22, 57). Therefore, any
animal behavioral paradigm must account for these confounding
variables when assessing animals for tinnitus.
Researchers using Gap-PPI, including our lab, have attempted
to account for salicylate-induced hearing loss and gap detection
deficits by using background noises of at least 60 dB SPL and 50 ms
silent gaps (19–21, 24). Using these, and similar, stimulus para-
meters, researchers have consistently found Gap-PPI deficits, i.e.,
reduced inhibition, in animals following salicylate exposure and
have attributed these deficits to the presence of tinnitus (19, 20).
However, the results of the current experiment, along with recent
human psychoacoustic and startle reflex data, call into question
what the Gap-PPI paradigm is modeling (32). If hearing loss
and gap detection deficits are not producing these changes in
Gap-PPI because the stimuli are presented at high sound levels
(~60 dB SPL), with long-duration gaps (~50 ms), and if tinni-
tus is not filling in the silent gaps, as suggested by the current
results and recent human data (30, 54, 55), then it is not yet clear
what is producing Gap-PPI deficits following salicylate and noise
exposure.
One explanation for the changes in Gap-PPI following sali-
cylate or noise exposure could be related to hyperacusis. Briefly,
hyperacusis is defined as abnormal sound level tolerance where
moderate-level sounds are perceived as uncomfortably loud (58,
59). Both salicylate and noise exposure have recently been impli-
cated in the manifestation of hyperacusis in animals. Salicylate
has been shown to amplify acoustic startle responses (ASRs)
(8, 20) and alter loudness growth functions to moderate- and
high-level sounds (57) in rats. In addition, noise exposures that
result in either permanent threshold shifts (22) or only tem-
porary threshold shifts (60) have been shown to amplify ASRs
in animals, which may be indicative of hyperacusis (18). Given
these consistent changes to ASRs following salicylate and noise
exposure, this could be a confounding variable when measur-
ing Gap-PPI because PPI is not independent from baseline startle
reactivity (61, 62).
Another explanation for changes in Gap-PPI following salicy-
late are alterations in temporal processing. Sun et al. (63) found
that salicylate facilitates the perception of the onset of the gap, but
reduces the perception of the offset of the gap. In other words, sali-
cylate increases Gap-PPI by facilitating the response to the onset of
the gaps, while decreasing Gap-PPI when the offset of the gap is the
available cue (63). Since salicylate facilitated the ASR, (63) deter-
mined that these changes were not due to hearing loss. However,
since temporal integration is altered in humans given large doses
of aspirin (13), and since salicylate enhances the sound-evoked
onset responses of cortical neurons (9), it is possible that changes
in temporal integration following salicylate could explain the Sun
et al. (63) results, regardless of tinnitus.
Although the Gap-PPI paradigm has many advantages over
other animal models of tinnitus, it is not yet clear that tinnitus
alone can account for changes in Gap-PPI when both salicylate and
noise exposure appear to induce hearing loss, temporal processing
deficits, and hyperacusis as well (18, 32).
CONCLUDING REMARKS
In summary, the gap detection thresholds for rats in the current
study were unchanged with salicylate for BBN and NBN presented
at high-sound levels, suggesting that salicylate-induced tinnitus
was not“filling in” the conscious perception of the silent gaps. Fur-
thermore, given the threshold shifts found in the noise detection
experiments, the effects of salicylate on gap detection at low-sound
levels are most parsimoniously explained by hearing loss alone and
not caused by tinnitus. However, the possibility remains that tin-
nitus interferes with peripheral, pre-attentive filtering of sensory
stimuli involved in sensorimotor gating. As such, the conscious
perception of silent gaps in background noise may involve differ-
ent neural processes than those underlying prepulse inhibition of
the acoustic startle reflex; however, hearing loss, temporal process-
ing deficits, and hyperacusis remain confounding variables when
using traditional gap detection paradigms to measure tinnitus in
animals.
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